The Evolving Field of Treatment ModalitiesVideo Categories: 2018 AONN Midyear, Immunotherapy, and Video Library
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Drs. David Rimm and Roy Herbst identify the top challenges in the area of biomarker testing as well as solutions to these challenges, including availability of sufficient tissue for a large number of biomarker assays, the time some biomarker tests require for completion, the need for a tight association of [ Read More ]
Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the circumstances in which they would use the Breast Cancer IndexSM (BCI) to assist in determining whether to extend the adjuvant therapy of women with breast cancer beyond 5 years.